ORGANIC
LETTERS
2002
Vol. 4, No. 6
901-904
In Search of High Stereocontrol for the
Construction of cis-Disubstituted
Cyclopropane Compounds. Total
Synthesis of a Cyclopropane-Configured
Urea-PETT Analogue That Is a HIV-1
Reverse Transcriptase Inhibitor
Wenhao Hu, Daren J. Timmons, and Michael P. Doyle*
Department of Chemistry, UniVersity of Arizona, Tucson, Arizona 85721
Received December 19, 2001
ABSTRACT
A new azetidine-ligated dirhodium(II) catalyst that possesses a l-menthyl ester attachment provides significant diastereocontrol and high
enantiocontrol for the formation of cis-cyclopropane products from reactions of substituted styrenes with diazo esters.
Recently considerable attention has been directed to a new
class of potent non-nucleoside HIV-1 reverse transcriptase
inhibitors structurally defined as phenylethylthiazolylthiourea
(PETT) derivatives.1-4 Subsequent research revealed that the
urea-PETT analogues had toxicological and pharmacokinetic
advantages over the thiourea derivatives and that their
antiviral activity in cell culture in the presence of human
serum was superior to that of the thiourea compounds.5,6 The
most advantageous of the compounds examined were cis-
cyclopropyl derivatives, designated by 1, but stereoselective
synthesis of the cis-disubstituted ring from a multisubstituted
styrene was the greatest obstacle.
(1) Ahgren, C.; Ba¨ckbro, K.; Bell, F. W.; Cantrell, A. S.; Clemens, M.;
Colacino, J. M.; Deeter, J. B.; Engelhardt, J. A.; Ho¨gberg, M.; Jaskunas, S.
R.; Johansson, N. G.; Jordan, C. L.; Kasher, J. S.; Kinnick, M. D.; Lind,
P.; Lopez, D.; Morin, Jr., J. M.; Muesing, M. A.; Nore´en, R.; O¨ berg, B.;
Paget, C. J.; Palkowitz, J. A.; Parrish, C. A.; Pranc, P.; Rippy, M. K.;
Rydergard, C.; Sahlberg, C.; Swanson, S.; Ternansky, R. J.; Unge, T.;
Vasileff, R. T.; Vrang, L.; West, S. J.; Zhang, H.; Zhou, X.-X. Antimicrob.
Agents Chemother. 1995, 39, 1329.
(2) Bell, F. W.; Cantrell, A. S.; Ho¨gberg, M.; Jaskunas, S. R.; Johansson,
N. G.; Nore´en, R.; O¨ berg, B.; Palkowitz, J. A.; Parrish, C. A.; Prane, P.;
Sahlberg, C.; Ternansky, R. J.; Vasileff, R. J.; Vrang, L.; West, S. J.; Zhang,
H.; Zhou, X.-X. J. Med. Chem. 1995, 38, 4929.
(3) Zhang, H.; Vrang, L.; Ba¨ckbro, K.; Lind, P.; Sahlberg, C.; Unge, T.;
O¨ berg, B. AntiViral Res. 1995, 28, 331.
(4) Cantrell, A. S.; Engelhardt, P.; Ho¨gberg, M.; Jaskunas, S. R.;
Johansson, N. G.; Jordan, C. L.; Kangasmetsa¨, J.; Kinnick, M. D.; Lind,
P.; Morin, J. M., Jr.; Muesing, M. A.; Nore´en, R.; O¨ berg, B.; Pranc, P.;
Sahlberg, C.; Ternansky, R. J.; Vasileff, R. T.; Vrang, L.; West, S. J.; Zhang,
H. J. Med. Chem. 1996, 39, 4261.
The preparation of cis-disubstituted cyclopropane com-
pounds has been particularly challenging, but several catalytic
(5) Sahlberg, C.; Nore´en, R.; Engelhardt, P.; Ho¨gberg, M.; Kangasmetsa¨,
J.; Vrang, L.; Zhang, H. Bioorg. Med. Chem. Lett. 1998, 8, 1511.
10.1021/ol017276b CCC: $22.00 © 2002 American Chemical Society
Published on Web 02/26/2002